Novartis splits drugs business into two, pharma chief to leave #pharmaceutical #conference

Posted On Nov 16 2017 by

#novartis pharma # Novartis splits drugs business into two, pharma chief to leave By John Miller and Ben Hirschler | ZURICH/LONDON ZURICH/LONDON (Reuters) – Novartis is splitting its pharmaceuticals division into two business units, one focused on cancer and the second on other drugs, while switching out its current pharma head in the second high-profile management reshuffle this year. David Epstein, the American head of Novartis Pharmaceuticals and a 27-year veteran with the group, will leave the company to “explore new challenges from the U.S.”, Novartis said. Epstein’s re-location to the United States implies he is not in the running …


Novartis Pharmaceuticals #pharmaceutical #companies #india

Posted On Nov 16 2017 by

#novartis pharma # • Promotions for Women into Management: 37.8% higher than the Top 10 and 52.2% higher than the Top 50 • Supplier Diversity: Double the Top 10 average and triple the Top 50 average on subcontractors who are minority owned • SupplierDiversity: Four times higher than the Top10 average and nine times higher than the Top 50 average of subcontractors who are women owned Novartis Pharmaceuticals Corporation (NPC) continues to maintain an impressive track record on the Top 50 list, and the company is well known for its proven commitment to promoting women into management positions. D I …


Novartis pharma head leaves as drug maker splits operations #helvoet #pharma

Posted On Nov 8 2017 by

#novartis pharma # Novartis pharma head leaves as drug maker splits operations Underscoring its increasing emphasis on oncology, Novartis is splitting its prescription drug business into two organizations and hired Paul Hudson, who heads North American operations for AstraZeneca, to lead the pharmaceutical business. The newly created oncology unit, meanwhile, will be run by Bruno Strigini, who already runs the cancer-drug business. The move comes a year after Novartis purchased a portfolio of oncology medicines from GlaxoSmithKline as part of an asset swap. But Novartis is also contending with declining sales of its Gleevec cancer medicine, which has been a …


Novartis splits drugs business into two, pharma chief to leave #plus #pharma

Posted On Nov 8 2017 by

#novartis pharma # Novartis splits drugs business into two, pharma chief to leave By John Miller and Ben Hirschler | ZURICH/LONDON ZURICH/LONDON (Reuters) – Novartis is splitting its pharmaceuticals division into two business units, one focused on cancer and the second on other drugs, while switching out its current pharma head in the second high-profile management reshuffle this year. David Epstein, the American head of Novartis Pharmaceuticals and a 27-year veteran with the group, will leave the company to “explore new challenges from the U.S.”, Novartis said. Epstein’s re-location to the United States implies he is not in the running …


Novartis Pharmaceuticals – Top Employers #pharma.org

Posted On Sep 9 2017 by

#novartis pharma # Novartis Pharmaceuticals was awarded the Top Employers United Kingdom 2016 certification. Our comprehensive independent research revealed that Novartis Pharmaceuticals provides exceptional employee conditions, nurtures and develops talent throughout all levels of the organisation and has demonstrated its leadership status in the HR environment, always striving to optimise its employment practices and to develop its employees. About Novartis Pharmaceuticals Novartis, created through the merger of Ciba–Geigy and Sandoz in 1996, provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative …


Novartis – sales performance, data and rankings – Top Pharma List #biocon #pharma

Posted On Sep 7 2017 by

#pharma company # Novartis Data by GlobalData GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value. To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com Featured jobs Director, Scientific Services Great salary and benefits ID Search Selection Principal Medical Writer Great salary and benefits ID Search Selection Director, Scientific Services 80 – …


Novartis Pharma en France: recherche et innovation au service des patients #hi #tech #pharma

Posted On Aug 30 2017 by

#novartis pharma # Neurologie monparkinson.fr Informations et conseils l’attention des patients atteints de la maladie de Parkinson. sep-et-vous.fr Conseils aux patients et leur entourage visant optimiser la prise en charge de la scl rose en plaques (SeP). sepenscene.com Site pour les patients atteints de scl rose en plaque et leur entourage Pneumologie bougeons-en-famille.com Site destination des patients atteints de Broncho-Pneumopathie Chronique Obstructive (BPCO) et leur entourage. Ophtamologie dmlainfo.fr Plateforme d informations pour les patients atteints de D g n rescence Maculaire Li e l ge (DMLA) et leurs proches. Dermatologie bienvivremapeau.fr Informations, actualit s et conseils l’attention des patients atteints …


Novartis – sales performance, data and rankings – Top Pharma List #pharmaceutical #contract #manufacturer

Posted On Aug 27 2017 by

#pharma company # Novartis Data by GlobalData GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value. To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com Featured jobs Director, Scientific Services Great salary and benefits ID Search Selection Principal Medical Writer Great salary and benefits ID Search Selection Director, Scientific Services 80 – …


Novartis Pharma en France: recherche et innovation au service des patients #pharmaceuticals #manufacturing

Posted On Aug 19 2017 by

#novartis pharma # Neurologie monparkinson.fr Informations et conseils l’attention des patients atteints de la maladie de Parkinson. sep-et-vous.fr Conseils aux patients et leur entourage visant optimiser la prise en charge de la scl rose en plaques (SeP). sepenscene.com Site pour les patients atteints de scl rose en plaque et leur entourage Pneumologie bougeons-en-famille.com Site destination des patients atteints de Broncho-Pneumopathie Chronique Obstructive (BPCO) et leur entourage. Ophtamologie dmlainfo.fr Plateforme d informations pour les patients atteints de D g n rescence Maculaire Li e l ge (DMLA) et leurs proches. Dermatologie bienvivremapeau.fr Informations, actualit s et conseils l’attention des patients atteints …


Novartis Pharmaceuticals – Top Employers #pharma #recruiting

Posted On Aug 10 2017 by

#novartis pharma # Novartis Pharmaceuticals was awarded the Top Employers United Kingdom 2016 certification. Our comprehensive independent research revealed that Novartis Pharmaceuticals provides exceptional employee conditions, nurtures and develops talent throughout all levels of the organisation and has demonstrated its leadership status in the HR environment, always striving to optimise its employment practices and to develop its employees. About Novartis Pharmaceuticals Novartis, created through the merger of Ciba–Geigy and Sandoz in 1996, provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative …